Levitee Labs Inc. carries a market capitalization of 369,155.00, placing it among publicly traded companies globally. Its enterprise value stands at 3.62M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 369,155.00 |
| Enterprise Value | 3.62M |
Levitee Labs Inc. currently has 75.82M shares outstanding.
| Shares Outstanding | 75.82M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 0.13, and the price-to-book ratio stands at 0.23.
| PE Ratio | N/A |
| PS Ratio | 0.13 |
| PB Ratio | 0.23 |
| P/TBV Ratio | -0.62 |
| P/FCF Ratio | -0.17 |
| P/OCF Ratio | -0.14 |
| EV / Sales | 0.46 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Levitee Labs Inc. maintains a current ratio of 0.45, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 59.67, indicating elevated leverage, while an interest coverage ratio of -235.98 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.45 |
| Quick Ratio | 0.19 |
| Debt / Equity | 59.67 |
| Debt / EBITDA | -0.36 |
| Interest Coverage | -235.98 |
| Return on Equity (ROE) | -459.18 |
| Return on Assets (ROA) | -89.73 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.56 |
Over the trailing twelve months, Levitee Labs Inc. generated 7.80M in revenue and converted that into -11.16M in net income, yielding earnings per share of -0.16. EBITDA reached -10.08M, while operating income came in at -10.51M.
| Revenue | 7.80M |
| Gross Profit | 2.22M |
| Operating Income | -10.51M |
| Pretax Income | -11.13M |
| Net Income | -11.16M |
| EBITDA | -10.08M |
| EBIT | -10.51M |
| Earnings Per Share (EPS) | -0.16 |
Levitee Labs Inc. holds 1.03M in cash and equivalents against 3.62M in total debt, resulting in a net debt position of 1.96M. Total book value stands at 4.49M, with working capital of -3.19M providing operational flexibility.
| Cash & Cash Equivalents | 1.03M |
| Total Debt | 3.62M |
| Net Debt | 1.96M |
| Equity (Book Value) | 4.49M |
| Book Value Per Share | 0.07 |
| Working Capital | -3.19M |
Levitee Labs Inc. produced -7.10M in operating cash flow over the past twelve months. After subtracting -1.16M in capital expenditures, free cash flow totaled -8.26M - equivalent to -0.12 per share.
| Operating Cash Flow | -7.10M |
| Capital Expenditures | -1.16M |
| Free Cash Flow | -8.26M |
| FCF Per Share | -0.12 |
Levitee Labs Inc. operates with a gross margin of 50.58, reflecting its pricing power and cost economics. The operating margin of -134.81 and net profit margin of -143.11 provide insight into operational efficiency.
| Gross Margin | 50.58 |
| Operating Margin | -134.81 |
| Pretax Margin | -142.74 |
| Profit Margin | -143.11 |
| EBITDA Margin | -129.32 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -1,427.31 |
| FCF Yield | -581.15 |
Levitee Labs Inc. posts an Altman Z-Score of -11.51, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -11.51 |